Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets ![]() |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 56,467,388 | $5,646,738,813.00 | 4.95% |
Microsoft Corp. | Equity | 16,777,505 | $4,836,954,692.00 | 4.24% |
Novo Nordisk A/S, Class B | Equity | 18,260,419 | $2,897,793,255.00 | 2.54% |
Taiwan Semiconductor Manufacturing Company, Ltd. | Equity | 151,721,941 | $2,687,886,398.00 | 2.36% |
Tesla, Inc. | Equity | 11,437,946 | $2,372,916,277.00 | 2.08% |
Meta Platforms, Inc., Class A | Equity | 10,352,949 | $2,194,204,011.00 | 1.92% |
Broadcom, Inc. | Equity | 2,750,453 | $1,764,525,618.00 | 1.55% |
ASML Holding NV | Equity | 2,451,167 | $1,674,870,097.00 | 1.47% |
AstraZeneca PLC | Equity | 11,434,304 | $1,587,083,122.00 | 1.39% |
LVMH Moët Hennessy-Louis Vuitton SE | Equity | 1,702,044 | $1,559,851,575.00 | 1.37% |
Nestle SA | Equity | 12,388,121 | $1,512,302,296.00 | 1.33% |
AIA Group, Ltd. | Equity | 142,739,583 | $1,499,819,179.00 | 1.31% |
Eli Lilly and Company | Equity | 4,077,060 | $1,400,143,945.00 | 1.23% |
DSV A/S | Equity | 5,666,597 | $1,093,746,617.00 | 0.96% |
Thermo Fisher Scientific, Inc. | Equity | 1,904,787 | $1,097,862,083.00 | 0.96% |